Reprogramming of human exocrine pancreas cells to beta cells

被引:5
作者
Staels, Willem [1 ,2 ,3 ]
Heremans, Yves [1 ]
Heimberg, Harry [1 ]
机构
[1] Vrije Univ Brussel, Diabet Res Ctr, B-1090 Brussels, Belgium
[2] Ghent Univ Hosp, Dept Pediat, Div Pediat Endocrinol, Ghent, Belgium
[3] Univ Ghent, Dept Pediat & Genet, B-9000 Ghent, Belgium
关键词
diabetes; pancreas; beta cell; reprogramming; transdifferentiation; IN-VITRO EXPANSION; ACINAR-CELLS; DUCTAL CELLS; STEM-CELLS; TRANSCRIPTION FACTORS; EXTRACELLULAR-MATRIX; EPIGENETIC MEMORY; MOUSE FIBROBLASTS; ALPHA CELLS; CONVERSION;
D O I
10.1016/j.beem.2015.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the key promises of regenerative medicine is providing a cure for diabetes. Cell-based therapies are proving their safety and efficiency, but donor beta cell shortages and immunological issues remain major hurdles. Reprogramming of human pancreatic exocrine cells towards beta cells would offer a major advantage by providing an abundant and autologous source of beta cells. Over the past decade our understanding of transdifferentiation processes greatly increased allowing us to design reprogramming protocols that fairly aim for clinical trials. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:849 / 857
页数:9
相关论文
共 50 条
  • [41] Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine
    Nostro, Maria Cristina
    Keller, Gordon
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2012, 23 (06) : 701 - 710
  • [42] Making β Cells from Adult Cells Within the Pancreas
    Lysy, Philippe A.
    Weir, Gordon C.
    Bonner-Weir, Susan
    CURRENT DIABETES REPORTS, 2013, 13 (05) : 695 - 703
  • [43] Are there any stem cells in the pancreas?
    Yalniz, M
    Pour, PM
    PANCREAS, 2005, 31 (02) : 108 - 118
  • [44] Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas
    Esni, F
    Stoffers, DA
    Takeuchi, T
    Leach, SD
    MECHANISMS OF DEVELOPMENT, 2004, 121 (01) : 15 - 25
  • [45] Regenerating β cells of the pancreas - potential developments in diabetes treatment
    Dong, Shengli
    Wu, Hongju
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (02) : 175 - 185
  • [46] Chemical reprogramming of human somatic cells to pluripotent stem cells
    Guan, Jingyang
    Wang, Guan
    Wang, Jinlin
    Zhang, Zhengyuan
    Fu, Yao
    Cheng, Lin
    Meng, Gaofan
    Lyu, Yulin
    Zhu, Jialiang
    Li, Yanqin
    Wang, Yanglu
    Liuyang, Shijia
    Liu, Bei
    Yang, Zirun
    He, Huanjing
    Zhong, Xinxing
    Chen, Qijing
    Zhang, Xu
    Sun, Shicheng
    Lai, Weifeng
    Shi, Yan
    Liu, Lulu
    Wang, Lipeng
    Li, Cheng
    Lu, Shichun
    Deng, Hongkui
    NATURE, 2022, 605 (7909) : 325 - +
  • [47] Reprogramming of Human Pancreatic Organoid Cells into Insulin-Producing β-Like Cells by Small Molecules and in Vitro Transcribed Modified mRNA Encoding Neurogenin 3 Transcription Factor
    Koblas, T.
    Leontovyc, I
    Loukotova, S.
    Saudek, F.
    FOLIA BIOLOGICA, 2019, 65 (03) : 109 - 123
  • [48] In-depth analysis of proteomic and genomic fluctuations during the time course of human embryonic stem cells directed differentiation into beta cells
    Budnik, Bogdan
    Straubhaar, Juerg
    Neveu, John
    Shvartsman, Dmitry
    PROTEOMICS, 2022, 22 (09)
  • [49] Reprogramming of Pancreatic Exocrine Cells AR42J Into Insulin-producing Cells Using mRNAs for Pdx1, Ngn3, and MafA Transcription Factors
    Koblas, Tomas
    Leontovyc, Ivan
    Loukotova, Sarka
    Kosinova, Lucie
    Saudek, Frantisek
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2016, 5 : e320
  • [50] Characterization of the Human Pancreas Side Population as a Potential Reservoir of Adult Stem Cells
    Augstein, Petra
    Loudovaris, Thomas
    Bandala-Sanchez, Esther
    Heinke, Peter
    Naselli, Gaetano
    Lee, Lily
    Hawthorne, Wayne J.
    Gonez, L. Jorge
    Neale, Alana M.
    Vaillant, Francois
    Thomas, Helen E.
    Kay, Thomas W.
    Banakh, Ilia
    Harrison, Leonard C.
    PANCREAS, 2018, 47 (01) : 25 - 34